1. New Anticoagulants for Stroke Prophylaxis in Atrial Fibrillation

   • Stephen Kopecky

   Review Article 12 December 2012 Pages: 287 - 294

   

2. How do Compliance, Convenience, and Tolerability Affect Blood Pressure Goal Rates?

   • Serap Erdine

   Review Article 12 December 2012 Pages: 295 - 302

   

3. Tangier Disease

   • Mariarita Puntoni
   • Francesco Sbrana
   • Tiziana Sampietro

   Therapy In Practice 12 December 2012 Pages: 303 - 311

   

4. Anticoagulation Therapy for Patients with Non-Valvular Atrial Fibrillation

   • Julian P. Casciano
   • Daniel E. Singer
   • Bradley C. Martin

   Original Research Article 12 December 2012 Pages: 313 - 323

   

5. Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

   • F. Wilford Germino
   • Joel M. Neutel
   • Kathleen J. Chavanu

   Original Research Article 12 December 2012 Pages: 325 - 333

   

6. Antihypertensive Effects of Olmesartan Compared with Other Angiotensin Receptor Blockers

   • Long Wang
   • Jian-wei Zhao
   • Xue-yin Shi

   Original Research Article 12 December 2012 Pages: 335 - 344

   

7. High Prevalence of Silent Brain Infarction in Patients Presenting with Mechanical Heart Valve Thrombosis

   • Parag Barwad
   • Amol Raheja
   • Ganesan Karthikeyan

   Short Communication 12 December 2012 Pages: 345 - 348

   

8. Association of Cholesteryl Ester Transfer Protein Mass with Peripheral Leukocyte Count Following Statin Therapy

   • Shigemasa Tani
   • Ken Nagao
   • Atsushi Hirayama

   Short Communication 12 December 2012 Pages: 349 - 354